highly significantP = 0.0014
Despite a three fold reduction in sample size compared to the full CADCZ patient group, the analysis of CAD patients with metabolic syndrome revealed highly significant association with increased effect size ( P = 0.0014, OR = 2.34; P = 0.0016, OR = 2.41; additive and dominant models, respectively).